Insight Molecular Diagnostics (IMDX) Return on Invested Capital (2020 - 2024)
Historic Return on Invested Capital for Insight Molecular Diagnostics (IMDX) over the last 3 years, with Q3 2024 value amounting to 2.63%.
- Insight Molecular Diagnostics' Return on Invested Capital changed N/A to 2.63% in Q3 2024 from the same period last year, while for Sep 2024 it was 2.63%, marking a year-over-year change of. This contributed to the annual value of 0.2% for FY2022, which is 6600.0% up from last year.
- As of Q3 2024, Insight Molecular Diagnostics' Return on Invested Capital stood at 2.63%.
- In the past 5 years, Insight Molecular Diagnostics' Return on Invested Capital ranged from a high of 0.28% in Q2 2021 and a low of 2.63% during Q3 2024
- In the last 3 years, Insight Molecular Diagnostics' Return on Invested Capital had a median value of 0.8% in 2020 and averaged 1.22%.
- Over the last 5 years, Insight Molecular Diagnostics' Return on Invested Capital had its largest YoY gain of -200bps in 2021, and its largest YoY loss of -200bps in 2021.
- Insight Molecular Diagnostics' Return on Invested Capital (Quarter) stood at 0.79% in 2020, then dropped by -2bps to 0.81% in 2021, then plummeted by -224bps to 2.63% in 2024.
- Its last three reported values are 2.63% in Q3 2024, 2.13% for Q2 2024, and 2.44% during Q1 2024.